A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Trial Profile

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Feb 2016

At a glance

  • Drugs Amlodipine/fimasartan/rosuvastatin (Primary) ; Amlodipine/fimasartan; Rosuvastatin
  • Indications Hyperlipidaemia; Hypertension
  • Focus Pharmacokinetics
  • Sponsors Boryung Pharmaceutical
  • Most Recent Events

    • 23 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top